Papers
3
Total Citations
26
H-Index
2
About
Bin Yu is a biotechnology researcher whose work sits at the critical intersection of cell line engineering and HIV vaccine development. Yu's research has focused primarily on optimizing the production of HIV envelope glycoproteins (Envs) in Chinese Hamster Ovary (CHO) cell systems — a notoriously difficult challenge, as Env yields are typically 10 to 100 times lower than other pharmaceutical glycoproteins. To address this bottleneck, Yu pioneered the application of robotic selection technologies to rapidly develop stable CHO cell lines capable of producing HIV vaccine candidates at viable scales, work that has accumulated 21 citations and represents a meaningful methodological advance for the field. Yu also contributed to the engineering of specialized MGAT1-deficient CHO cell lines to produce Clade C gp120 with enhanced binding to broadly neutralizing antibodies — a crucial property for vaccine efficacy, particularly relevant to combating the high HIV infection rates in Sub-Saharan Africa. Collectively, Yu's contributions help address fundamental manufacturing challenges that have long hindered HIV vaccine development, offering practical platforms that could accelerate the path toward a globally effective AIDS vaccine.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3